Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Bolka International is a Chinese pharmaceutical supplier specializing in manufacturing and exporting active pharmaceutical ingredients (APIs), intermediates, and plant extracts. The company offers a range of corticosteroid APIs such as betamethasone variants, budesonide, clobetasol propionate, cortisone acetate, and dexamethasone. Their business integrates R&D with international trade and focuses on supplying high-quality raw materials to global pharma manufacturers. There is no evidence that they conduct clinical trials or develop proprietary drugs; their focus is on B2B supply of bulk pharmaceuticals for further formulation or manufacture.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Bolka International.